Is intent-to-treat analysis always (ever) enough?
نویسندگان
چکیده
منابع مشابه
Is it ever enough to die of old age?
OBJECTIVE To determine how often 'old age' was given as a cause of death in patients presenting for cremation, with particular reference to their characteristics and the medical conditions known to the certifying doctor at the time of death. DESIGN Prospective review of all cremation papers presented to one crematorium over a two-year period. SETTING An English crematorium serving a populat...
متن کاملIntent-to-treat analysis for longitudinal studies with drop-outs.
We consider intent-to-treat (IT) analysis of clinical trials involving longitudinal data subject to drop-out. Common methods, such as Last Observation Carried Forward imputation or incomplete-data methods based on models that assume random dropout, have serious drawbacks in the IT setting. We propose a method that involves multiple imputation of the missing values following drop-out based on an...
متن کاملA Pragmatic Intent-to-Treat Analysis Using SAS
Intent-to-treat analyses are warranted in clinical trials, which usually contain right-censored data due to treatment failures or dropouts. An explanatory analysis, easily achieved with PROC MIXED, assumes data missing at random, which is not the case in clinical trials since the dropouts are often associated with the treatment assignments (Little and Rubin, 1987). A pragmatic analysis (Hogan a...
متن کاملSumming up evidence: one answer is not always enough.
Are meta-analyses the brave new world, or are the critics of such combined analyses right to say that the biases inherent in clinical trials make them uncombinable? Negative trials are often unreported, and hence can be missed by meta-analysts. And how much heterogeneity between trials is acceptable? A recent major criticism is that large randomised trials do not always agree with a prior meta-...
متن کاملExacerbations and intent-to-treat analyses in randomised trials.
In 1998 during a flight from Athens (Greece) to San Francisco (CA, USA), A.M. Hanson, an asthmatic doctor aged 52 yrs, died due to an asthmatic reaction to second-hand cigarette smoke. In 2004, the US Supreme Court ruled that Olympic Airways was to pay the widow of A.M. Hanson US$1.4 million. This successful lawsuit by a passenger against an airline over smoking was unprecedented, and smoking o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 2002
ISSN: 0306-5251
DOI: 10.1046/j.1365-2125.2002.01628.x